Origin Therapeutics Holdings, Inc. Financial Overview
Origin Therapeutics Holdings, Inc.'s market cap is currently C$8.45M. The company's EPS TTM is C$-0.002; its P/E ratio is ―; Origin Therapeutics Holdings, Inc. is scheduled to report earnings on September 2, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23
Sep 22
Sep 21
Currency in USD
Origin Therapeutics Holdings, Inc. Earnings and Revenue History
